Pink Sheet: global policy and regulatory coverage
House GOP Targets US FDA Applications With China-Only Data, Raise General Oversight Concerns
By Derrick Gingery 24 May 2022
While industry concern with FDA’s policy shift on clinical data from China has focused on the disruption in business plans...